Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 250 entries
View as:

A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT05531279 Org: User:
Start: 06/05/22 End: 01/05/26 Due: 01/05/27

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT01719692 Org: User:
Start: 10/31/12 End: 02/29/16 Due: 02/28/17

The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT02844322 Org: User:
Start: 05/31/16 End: 05/31/20 Due: 05/31/21

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Phase: N/A Priority: Normal
NCT ID: NCT04390971 Org: User:
Start: 02/10/23 End: 08/15/25 Due: 08/15/26

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT05632380 Org: User:
Start: 07/14/22 End: 06/30/25 Due: 06/30/26

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Phase: N/A Priority: Normal
NCT ID: NCT06367374 Org: User:
Start: 05/30/24 End: 07/30/30 Due: 07/30/31

Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT02844361 Org: User:
Start: 05/31/16 End: 05/31/20 Due: 05/31/21

Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

Phase: N/A Priority: Normal
NCT ID: NCT06489808 Org: User:
Start: 05/28/24 End: 05/31/27 Due: 05/31/28

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase: N/A Priority: Normal
NCT ID: NCT04453345 Org: User:
Start: 05/20/13 End: 05/20/25 Due: 05/20/26

Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05676710 Org: User:
Start: 02/10/23 End: 02/14/24 Due: 02/14/25

Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06302699 Org: User:
Start: 05/01/23 End: 03/01/26 Due: 03/01/27

Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT02287831 Org: User:
Start: 02/28/14 End: 12/26/22 Due: 12/26/23

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06594640 Org: User:
Start: 05/30/24 End: 07/30/27 Due: 07/30/28

ctDNA Methylation Sequencing for Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05578625 Org: User:
Start: 08/31/22 End: 06/30/25 Due: 06/30/26

Avatrombopag Combined With IST as First-line Treatment for SAA

Phase: N/A Priority: Normal
NCT ID: NCT05720234 Org: User:
Start: 11/10/22 End: 11/30/24 Due: 11/30/25

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

Phase: N/A Priority: Normal
NCT ID: NCT05870475 Org: User:
Start: 06/30/23 End: 05/31/28 Due: 05/31/29

Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model

Phase: N/A Priority: Normal
NCT ID: NCT05600855 Org: User:
Start: 01/15/23 End: 12/01/24 Due: 12/01/25

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Phase: N/A Priority: Normal
NCT ID: NCT06244368 Org: User:
Start: 01/17/24 End: 12/30/27 Due: 12/30/28

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

Phase: N/A Priority: Normal
NCT ID: NCT05846763 Org: User:
Start: 11/01/22 End: 05/31/28 Due: 05/31/29

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

Phase: N/A Priority: Normal
NCT ID: NCT06900114 Org: User:
Start: 10/07/23 End: 10/31/25 Due: 10/31/26

Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients

Phase: N/A Priority: Normal
NCT ID: NCT06900088 Org: User:
Start: 04/25/25 End: 10/30/26 Due: 10/30/27

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Phase: N/A Priority: Normal
NCT ID: NCT05599256 Org: User:
Start: 02/09/23 End: 12/01/25 Due: 12/01/26

Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06955858 Org: User:
Start: 05/30/25 End: 12/30/26 Due: 12/30/27

The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA

Phase: N/A Priority: Normal
NCT ID: NCT05518331 Org: User:
Start: 06/01/22 End: 01/01/26 Due: 01/01/27

BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06793449 Org: User:
Start: 01/31/25 End: 12/31/30 Due: 12/31/31